A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,878,595 shares of IMNM stock, worth $45 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,878,595
Previous 1,516,454 155.77%
Holding current value
$45 Million
Previous $37.4 Million 25.39%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.54 - $22.11 $27.3 Million - $52.2 Million
2,362,141 Added 155.77%
3,878,595 $46.9 Million
Q1 2024

May 15, 2024

BUY
$11.01 - $27.34 $16.7 Million - $41.5 Million
1,516,454 New
1,516,454 $37.4 Million

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $141M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.